Basinger Healthcare, which is one of the largest manufacturers of medical equipment and equipment suppliers in the United States, is the second largest medical equipment wholesaler in the world after Walmart.
It has an annual revenue of $2.8 billion, according to data from the US Bureau of Economic Analysis.BME’s stock price has risen in recent weeks.
On October 3, the company’s stock reached an all-time high of $1,967 per share, the highest price in history.
However, the price jumped to $2,000 per share on November 18.
On December 13, the stock jumped another $600, reaching an all time high of more than $2 million per share.
On January 2, the shares reached an impressive $2 billion market cap.
However the stock price dropped to $1.9 billion by February 7, according the NASDAQ Stock Market Index.
According to Bloomberg, BME’s share price rose from $2 per share in October to $3.05 per share by November 12.
However, the current stock price is only a fraction of its previous price of $3 per share that it bought at the beginning of the year.
The company reported a net loss of $5.3 million in the third quarter of 2018, and a net profit of $16.6 million in 2019.
On February 15, Basinger announced that it was ceasing operations.
It stated that it would take a $20 million write-down of all of its assets, including all assets related to its medical equipment business.
The company said that it had reached an agreement with the Department of Justice to sell certain assets, but it also stated that a third party will take over the management of the medical equipment company.
The sale of assets will be contingent upon the DOJ agreeing to the terms of the deal, Basiger said in a statement.
The deal will include all of Basinger’s assets and businesses including its medical supplies and medical equipment manufacturing operations, according a statement from the company.
Basinger Healthcare has been a leader in the medical device industry for over 100 years.
It is currently ranked fourth in the Fortune 500, according data from S&P Global Market Intelligence.
It had a total revenue of approximately $3 billion in 2018, according US Department of Health and Human Services data.